UPI: Contrast agents used for MRIs found accumulating in patients’ brains

| Posted in Brain Education, Brain Health, Brain Research

New research suggests doctors conduct a risk-benefit analysis before administering gadolinium, a common contrast agent injected into a patient’s veins before undergoing an MRI scan. Recent studies have shown contrast agent deposits can accumulate in the brain. In some patients, excessive exposure to contrast agents can harm the liver and pancreas. (August 7, 2017)

Read the full article here